Patents Assigned to KT&G LIFE SCIENCES CORPORATION
  • Publication number: 20160376258
    Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in Claim 1.
    Type: Application
    Filed: December 30, 2014
    Publication date: December 29, 2016
    Applicant: KT&G LIFE SCIENCES CORPORATION
    Inventors: Whee Seong LEE, Mi Jung LEE, Bo Jung KIM, Tae Cheul ROH, Seung Hoon LEE, Kyu Dae LEE, You-Hui LEE, Tae Hwan KWAK
  • Publication number: 20160376243
    Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R3, and X1 to X6 are the same as defined in Claim 1.
    Type: Application
    Filed: December 30, 2014
    Publication date: December 29, 2016
    Applicant: KT&G LIFE SCIENCES CORPORATION
    Inventors: Whee Seong LEE, Mi Jung LEE, Bo Jung KIM, Tae Cheul ROH, Seung Hoon LEE, Kyu Dae LEE, You-Hui LEE, Tae Hwan KWAK
  • Publication number: 20120289577
    Abstract: The present invention relates to a composition for treating or preventing hearing loss comprising naphthoquinone-based compounds.
    Type: Application
    Filed: December 27, 2010
    Publication date: November 15, 2012
    Applicant: KT&G LIFE SCIENCES CORPORATION
    Inventors: Tae Hwan Kwak, Myung-Gyu Park, Hong-Seob So, Raekil Park, Hyung-Jin Kim